Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

A study conducted by a multinational research group investigated the potential of audible sound waves (in the form of music, specifically Pink Floyd’s "Another Brick in the Wall, Part 1") in enhancing ...

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced the promotion of Prashant Nambiar, DVM, PhD, MBA, as Chief Scientific Officer and appointment of Ethan Cash as ...

Researchers can use messenger RNA to trigger the immune system to attack tumors. By stimulating cancer cells to produce a ...

According to Nova One Advisor, the global RNA therapeutics market size is calculated at USD 8.55 billion in 2025 and is ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.